Enregistré dans:
| Auteurs principaux: | Chun‐Ting Ho, Chia‐Chu Fu, Elise Chia‐Hui Tan, Wei‐Yu Kao, Pei‐Chang Lee, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | https://onlinelibrary.wiley.com/doi/10.1111/jgh.16640 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia
par: Teh‐Ia Huo, et autres
Publié: (2025)
par: Teh‐Ia Huo, et autres
Publié: (2025)
MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
par: Soe Thiha Maung, et autres
Publié: (2024)
par: Soe Thiha Maung, et autres
Publié: (2024)
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma
par: Hidenori Toyoda, et autres
Publié: (2024)
par: Hidenori Toyoda, et autres
Publié: (2024)
Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
par: Xu Zhang, et autres
Publié: (2024)
par: Xu Zhang, et autres
Publié: (2024)
Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome
par: Hiroaki Sugita, et autres
Publié: (2024)
par: Hiroaki Sugita, et autres
Publié: (2024)
Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis
par: Mayssan Muftah, et autres
Publié: (2024)
par: Mayssan Muftah, et autres
Publié: (2024)
Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma
par: Zhaodan Xin, et autres
Publié: (2024)
par: Zhaodan Xin, et autres
Publié: (2024)
Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
par: Qi‐Hang Cao, et autres
Publié: (2024)
par: Qi‐Hang Cao, et autres
Publié: (2024)
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: A treatment dilemma
par: Teh‐Ia Huo, et autres
Publié: (2024)
par: Teh‐Ia Huo, et autres
Publié: (2024)
Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature
par: Odysseas P. Chatzipanagiotou, et autres
Publié: (2024)
par: Odysseas P. Chatzipanagiotou, et autres
Publié: (2024)
Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
par: Tyng‐Yuan Jang, et autres
Publié: (2024)
par: Tyng‐Yuan Jang, et autres
Publié: (2024)
Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
par: Seung Kak Shin, et autres
Publié: (2024)
par: Seung Kak Shin, et autres
Publié: (2024)
Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
par: Keito Suzuki, et autres
Publié: (2024)
par: Keito Suzuki, et autres
Publié: (2024)
Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy
par: NM Batt, et autres
Publié: (2024)
par: NM Batt, et autres
Publié: (2024)
Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility
par: Connor Henry‐Blake, et autres
Publié: (2024)
par: Connor Henry‐Blake, et autres
Publié: (2024)
Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
par: Tyng‐Yuan Jang, et autres
Publié: (2025)
par: Tyng‐Yuan Jang, et autres
Publié: (2025)
Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
par: Yi‐Ting Chen, et autres
Publié: (2024)
par: Yi‐Ting Chen, et autres
Publié: (2024)
Developing a feasible classification model for surgical hepatocellular carcinoma: More questions than answers
par: Teh‐Ia Huo, et autres
Publié: (2024)
par: Teh‐Ia Huo, et autres
Publié: (2024)
Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
par: Ka Shing Cheung, et autres
Publié: (2024)
par: Ka Shing Cheung, et autres
Publié: (2024)
Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
par: Jungnam Lee, et autres
Publié: (2024)
par: Jungnam Lee, et autres
Publié: (2024)
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents
par: Hideko Ohama, et autres
Publié: (2024)
par: Hideko Ohama, et autres
Publié: (2024)
Short and Endurance Squeeze Contractile Integral in High‐Resolution Anorectal Manometry Is Correlated With Vaizey Incontinence Score—A Pilot Study
par: Jia‐Feng Wu, et autres
Publié: (2025)
par: Jia‐Feng Wu, et autres
Publié: (2025)
Distinct characteristics of various autoimmune liver diseases: A 22‐year hospital‐based study in Taiwan
par: Ming‐Ling Chang, et autres
Publié: (2024)
par: Ming‐Ling Chang, et autres
Publié: (2024)
Clinical Trial: The Optimal Timing of the Endoscope Insertion After Oral Lidocaine Spray. A Randomized Controlled Trial
par: Hsueh‐Chien Chiang, et autres
Publié: (2025)
par: Hsueh‐Chien Chiang, et autres
Publié: (2025)
Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
par: Yu‐Hsuan Kuo, et autres
Publié: (2025)
par: Yu‐Hsuan Kuo, et autres
Publié: (2025)
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B
par: Cheng‐Hao Tseng, et autres
Publié: (2025)
par: Cheng‐Hao Tseng, et autres
Publié: (2025)
Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real‐World Evidence From Regorafenib and Trifluridine/Tipiracil Use
par: Ya‐Wen Chang, et autres
Publié: (2025)
par: Ya‐Wen Chang, et autres
Publié: (2025)
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registry
par: Rheun‐Chuan Lee, et autres
Publié: (2024)
par: Rheun‐Chuan Lee, et autres
Publié: (2024)
Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE
par: Lingfeng Diao, et autres
Publié: (2024)
par: Lingfeng Diao, et autres
Publié: (2024)
Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
par: Hao‐Chien Hung, et autres
Publié: (2024)
par: Hao‐Chien Hung, et autres
Publié: (2024)
Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
par: Mei‐Tong Nie, et autres
Publié: (2024)
par: Mei‐Tong Nie, et autres
Publié: (2024)
The impact of sodium‐glucose cotransporter‐2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer
par: Cho‐Han Chiang, et autres
Publié: (2024)
par: Cho‐Han Chiang, et autres
Publié: (2024)
Gastrointestinal: An unusual large pancreatic head tumor: Pancreatic acinar cell carcinoma
par: H‐C Oh, et autres
Publié: (2024)
par: H‐C Oh, et autres
Publié: (2024)
Prevalence and disease burden of gastroparesis in Asia
par: Ching‐Tung Hsu, et autres
Publié: (2024)
par: Ching‐Tung Hsu, et autres
Publié: (2024)
Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease
par: Meng‐Lun Hsieh, et autres
Publié: (2026)
par: Meng‐Lun Hsieh, et autres
Publié: (2026)
Gastrointestinal: An Unexpected Scene of Epigastric Pain in Chronic Pancreatitis
par: Meng‐Hsuan Lu, et autres
Publié: (2025)
par: Meng‐Hsuan Lu, et autres
Publié: (2025)
Gastrointestinal: Colorectal metastases from gastric poorly differentiated carcinoma presenting as a diminutive polyp
par: K Shiotsuki, et autres
Publié: (2024)
par: K Shiotsuki, et autres
Publié: (2024)
Regression of liver fibrosis after HBsAg loss: A prospective matched case–control evaluation using transient elastography and serum enhanced liver fibrosis test
par: Lung‐Yi Mak, et autres
Publié: (2024)
par: Lung‐Yi Mak, et autres
Publié: (2024)
Relationship between Helicobacter pylori infection, osteoporosis, and fracture
par: Jing Tong Tan, et autres
Publié: (2024)
par: Jing Tong Tan, et autres
Publié: (2024)
Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures
par: Xiong Pei, et autres
Publié: (2024)
par: Xiong Pei, et autres
Publié: (2024)
Documents similaires
-
Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia
par: Teh‐Ia Huo, et autres
Publié: (2025) -
MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
par: Soe Thiha Maung, et autres
Publié: (2024) -
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma
par: Hidenori Toyoda, et autres
Publié: (2024) -
Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
par: Xu Zhang, et autres
Publié: (2024) -
Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome
par: Hiroaki Sugita, et autres
Publié: (2024)